Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

NEW ISSUE: Synlab E370m 5.5NC1 holdco sr PIK toggle notes, IPT mid 9s, on the road

HYC European Market: Deal Flow - General

Ephios Subco1 S.à r.l.

5.5yr

1y

Jan-32

€370m

Senior

PIK Toggle

Mid 9%s

IPTs: 5.5yr: Mid 9%s

  • Issuer: Ephios Subco1 S.à r.l.
  • Company: Synlab
  • Ticker: SYABEP
  • Business: leading provider of clinical laboratory and medical diagnostic services in Europe. Equity sponsor: Cinven. HQ: Munich, Germany.
  • Equity sponsor: Cinven.
  • Issue: HoldCo Senior PIK Toggle Notes (PIYC)
  • Existing Corporate Ratings: B2/B/B (Moody's/S&P/Fitch)
  • Size: €370m
  • Maturity: Jan-2032 (5.5-years)
  • PIK Interest Rate: 75 basis points higher than the cash interest rate per annum
  • Use Of Proceeds: Refinancing of the existing PIK instrument, alongside proceeds form the amended and restated PIK Loan
  • Call Protection: NC1 (101, Par)
  • Equity Claw: up to 40% at Par + coupon during NC period
  • Listing: Application will be made to the Official List of The International Stock Exchange
  • Distribution: Reg S / 144A
  • Governing Law: New York
  • Minimum Denomination: €100k x €1
  • Joint Global Coordinators & Physical Bookrunners: Citi (B&D), DB
  • Joint Bookrunners: Barclays, BNP, Credit Agricole, Goldman Sachs, HSBC, Mizuho, Natixis, RBI, Santander, SMBC, Unicredit
  • Marketing:
    • Global Investor Call: 3:30pm UKT today, 11-May
    • Small Group Meetings: 12-13-May (virtual)
  • NetRoadshow Registration: https://www.netroadshow.com/events/login/1PeTHmohYCt9ZcSiGRsyEzsrVKZmyqXOPFPQh
  • Roadshow Slides Link: www.netroadshow.com/nrs/home/#!/?show=7f1fc62e, Entry code: SYNLAB2026
  • Target Market: Manufacturer target market (MiFID II / UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPS / UK PRIIPS Key Information Document (KID) or CCI product summary has been prepared as not available to retail in EEA or the UK
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.